Paradigm Biopharmaceuticals Embraces Corporate Governance

Paradigm Biopharmaceuticals Ltd. (AU:PAR) has released an update.

Paradigm Biopharmaceuticals Ltd. has updated its corporate governance statement for the year ended June 30, 2024, which is now accessible via their website. The company has adhered to the ASX Corporate Governance Council’s recommendations throughout the period, as detailed in the statement approved by the board on August 29, 2024. The full declaration outlines the roles and responsibilities of the board and management and affirms the company’s commitment to transparency and governance best practices.

For further insights into AU:PAR stock, check out TipRanks’ Stock Analysis page.